Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

Clinical Features and Outcomes of Localized Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma: A Dual-Center Retrospective Observational Study with a Long-Term Follow-up

Blood (2024) 144 (Supplement 1): 3026.

https://doi.org/10.1182/blood-2024-193605

Published: 2024

Journal Articles

Randomized Phase III Study of Watchful Waiting Vs. Rituximab As First-Line Treatment in Patients with Advanced Stage Low Tumor Burden Follicular Lymphoma: JCOG1411/Flora Study

Blood (2024) 144 (Supplement 1): 338.

https://doi.org/10.1182/blood-2024-199868

Published: 2024

Journal Articles

Number of Sites of Involvement Predicts Central Nervous System Relapse in Patients with Localized Extranodal Natural Killer/T-Cell Lymphoma

Blood (2024) 144 (Supplement 1): 3058.

https://doi.org/10.1182/blood-2024-198371

Published: 2024

Journal Articles

Comparison of Clinical Characteristics and Prognosis between Aggressive NK-Cell Leukemia and Advanced-Stage Extranodal NK/T-Cell Lymphoma

Ayumi Fujimoto, Kana Miyazaki, Takeshi Maeda, Kimikazu Yakushijin, Wataru Munakata, Takahiro Fujino, Yasuo Ejima, Nobuhiro Hiramoto, Noriko Fukuhara, Jun Takizawa, Dai Maruyama, Nobuko Kubota, Hideki Goto, Rika Sakai, Senzo Taguchi, Naoko Asano, Fumihiro Ishida, Motoko Yamaguchi, Ritsuro Suzuki

Blood (2024) 144 (Supplement 1): 1682.

https://doi.org/10.1182/blood-2024-205065

Published: 2024

Journal Articles

Impact of Progression-Free Survival at 24 Months on Subsequent Survival in Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP Therapy: A Supplementary Analysis of JCOG0601

Ayumi Fujimoto, Wataru Munakata, Gakuto Ogawa, Tomotaka Suzuki, Kazuyuki Shimada, Tsutomu Kobayashi, Ken Ohmachi, Tomohiro Kinoshita, Kiyoshi Ando, Dai Maruyama, Hirokazu Nagai

Blood (2023) 142 (Supplement 1): 4499.

https://doi.org/10.1182/blood-2023-173433

Published: 2023

Journal Articles

The Prognostic Impact of Relative Dose Intensity of Vincristine in R-CHOP for Untreated Patients with Diffuse Large B-Cell Lymphoma: A Supplementary Analysis of JCOG0601

Takahiro Nakashima, Tomotaka Suzuki, Gakuto Ogawa, Kazuyuki Shimada, Tsutomu Kobayashi, Dai Maruyama, Wataru Munakata, Ken Ohmachi, Tomohiro Kinoshita, Kiyoshi Ando, Hirokazu Nagai

Blood (2023) 142 (Supplement 1): 1741.

https://doi.org/10.1182/blood-2023-174354

Published: 2023

Journal Articles

Final Analysis of the Randomized Phase II/III Study of Standard R-CHOP Versus CHOP Combined with Dose-Dense Weekly Rituximab for DLBCL: JCOG0601

Blood (2023) 142 (Supplement 1): 1724.

https://doi.org/10.1182/blood-2023-178551

Published: 2023

Journal Articles

Interim PET-Guided ABVD or ABVD/Escalated BEACOPP for Newly Diagnosed Advanced-Stage Classic Hodgkin Lymphoma (JCOG1305, INNOVATE-HL study)

Blood (2022) 140 (Supplement 1): 3718–3720.

https://doi.org/10.1182/blood-2022-157006

Published: 2022

Journal Articles

Two -Year Follow-up Data of Phase II Study of Tirabrutinib, a Second-Generation Bruton's Tyrosine Kinase Inhibitor, in Patients with Treatment-Naïve or Relapsed/Refractory Waldenström's Macroglobulinemiatwo -Year Follow-up Data of Phase II Study of Tirabrutinib, a Second-Generation Bruton's Tyrosine Kinase Inhibitor, in Patients with Treatment-Naïve or Relapsed/Refractory Waldenström's Macroglobulinemia

Kenshi Suzuki, Naohiro Sekiguchi, Shinya Rai, Wataru Munakata, Hiroshi Handa, Hirohiko Shibayama, Tomoyuki Endo, Yasuhito Terui, Noriko Iwaki, Noriko Fukuhara, Hiro Tatetsu, Shinsuke Iida, Takayuki Ishikawa, Daisuke Iguchi, Koji Izutsu

Blood (2021) 138 (Supplement 1): 1352.

https://doi.org/10.1182/blood-2021-146744

Published: 2021

Journal Articles

Phase 2 Study of Tirabrutinib (ONO/GS-4059), a Second-Generation Bruton's Tyrosine Kinase Inhibitor, Monotherapy in Patients with Treatment-Naïve or Relapsed/Refractory Waldenström Macroglobulinemia

Wataru Munakata, Naohiro Sekiguchi, MD PhD, Rai Shinya, MD,PhD, Kenshi Suzuki, MD PhD, Hiroshi Handa, MD PhD, Hirohiko Shibayama, MD PhD, Tomoyuki Endo, MD PhD, Yasuhito Terui, MD PhD, Noriko Iwaki, MD PhD, Noriko Fukuhara, MD PhD, Hiro Tatetsu, MD PhD, Shinsuke Iida, MD PhD, Takayuki Ishikawa, MD PhD, Ryota Shiibashi, Koji Izutsu, MD PhD

Blood (2019) 134 (Supplement_1): 345.

https://doi.org/10.1182/blood-2019-124614

Published: 2019

Journal Articles

Genomics of Limited-Stage Diffuse Large B-Cell Lymphoma Developing Late Relapse: Analysis of Gene Alterations in Paired Primary and Late Relapsed Tumors By Target Sequencing

Tomotaka Suzuki, MD, Suguru Fukuhara, MD, Junko Nomoto, PhD, Satoshi Yamashita, PhD, Akiko Miyagi Maeshima, MD PhD, Yuta Ito, MD, Shunsuke Hatta, MD PhD, Sayako Yuda, MD PhD, Shinichi Makita, MD, PhD, Wataru Munakata, MD PhD, Tatsuya Suzuki, MD, PhD, Dai Maruyama, MD PhD, Hirokazu Taniguchi, MD, PhD, Toshikazu Ushijima, MD PhD, Koji Izutsu, MDPhD, Kensei Tobinai, MD PhD, Yukio Kobayashi, MDDSc

Blood (2018) 132 (Supplement 1): 1571.

https://doi.org/10.1182/blood-2018-99-111262

Published: 2018

Journal Articles

Prognostic relevance of integrated genetic profiling in adult T-cell leukemia/lymphoma

Blood (2018) 131 (2): 215–225.

https://doi.org/10.1182/blood-2017-01-761874

Published: 2018

Includes: Supplemental data

Journal Articles

Impact of the Double Expression of MYC and BCL2 on Outcomes of Primary Refractory Diffuse Large B-Cell Lymphoma Following R-CHOP Chemoimmunotherapy

Tomotaka Suzuki, MD, Dai Maruyama, MD PhD, Akiko Miyagi Maeshima, MD PhD, Kinuko Tajima, Yuta Ito, MD, Shunsuke Hatta, MD PhD, Sayako Yuda, MD, PhD, Shinichi Makita, MD, PhD, Suguru Fukuhara, MD, Wataru Munakata, MD PhD, Tatsuya Suzuki, MD, PhD, Hirokazu Taniguchi, MD, Yukio Kobayashi, MD PhD, Koji Izutsu, MD, PhD, Kensei Tobinai, MD PhD

Blood (2017) 130 (Supplement 1): 2846.

https://doi.org/10.1182/blood.V130.Suppl_1.2846.2846

Published: 2017

Journal Articles

Comparison of Genetic Profiling of Primary Central Nervous System (CNS) Lymphoma before and after Extra-CNS Relapse

Kosuke Toyoda, MD, Junko Nomoto, MD PhD, Yasuji Miyakita, MD, Yoshitaka Narita, MD PhD, Akiko Miyagi Maeshima, MD PhD, Nobuhiko Yamauchi, MD, Suguru Fukuhara, MD, Wataru Munakata, MD PhD, Dai Maruyama, MD PhD, Kensei Tobinai, MD PhD, Yukio Kobayashi, MD PhD

Blood (2017) 130 (Supplement 1): 5135.

https://doi.org/10.1182/blood.V130.Suppl_1.5135.5135

Published: 2017

Journal Articles

Variegated RHOA mutations in adult T-cell leukemia/lymphoma

Blood (2016) 127 (5): 596–604.

https://doi.org/10.1182/blood-2015-06-644948

Published: 2016

Includes: Supplemental data

Journal Articles

Frequent Activating Somatic Alterations in T-Cell Receptor / NF-κb Signaling in Adult T-Cell Leukemia/Lymphoma

Keisuke Kataoka, MD PhD, Yasunobu Nagata, MDPhD, Akira Kitanaka, MD PhD, Yuichi Shiraishi, MD PhD, Jun-ichirou Yasunaga, MDPhD, Yasushi Totoki, Kenichi Chiba, BA, Aiko Sato-Otsubo, PhD, Shinichi Kotani, Masashi Sanada, MD PhD, Hiroko Tanaka, BA, Hiromichi Suzuki, MD PhD, Yusuke Sato, MD PhD, Yusuke Shiozawa, MD, Tetsuichi Yoshizato, MD, Kenichi Yoshida, MD PhD, Hideki Makishima, MD PhD, Guangyong Ma, Kisato Nosaka, MD PhD, Masakatsu Hishizawa, MD PhD, Hidehiro Itonaga, MD PhD, Yoshitaka Imaizumi, MD PhD, Wataru Munakata, MD, Nakamura Hiromi, Natsuko Hama, Kotaro Shide, MD PhD, Yoko Kubuki, Tomonori Hidaka, Takuro Kameda, Tsuyoshi Nakamaki, MD, Ken Ishiyama, MD PhD, Shuichi Miyawaki, MD, Kensei Tobinai, MD PhD, Yasushi Miyazaki, MD PhD, Akifumi Takaori-Kondo, MD PhD, Toshiki Watanabe, MD, PhD, Tatsuhiro Shibata, Masao Matsuoka, MD PhD, Satoru Miyano, MD PhD, Kazuya Shimoda, MD PhD, Seishi Ogawa, MD PhD

Blood (2015) 126 (23): 113.

https://doi.org/10.1182/blood.V126.23.113.113

Published: 2015

Journal Articles

Role of FDG-PET/CT in the Staging of Patients with Follicular Lymphoma

Sayako Yuda, MD, Dai Maruyama, MD PhD, Hiroaki Kurihara, MD, Akiko Miyagi Maeshima, MD, Kosuke Toyoda, MD, Yamauchi Nobuhiko, MD, Shin-ichi Makita, MD, Suguru Fukuhara, MD, Wataru Munakata, MD, Yukio Kobayashi, MD PhD, Hirokazu Taniguchi, MD, Kensei Tobinai, MD PhD

Blood (2015) 126 (23): 5010.

https://doi.org/10.1182/blood.V126.23.5010.5010

Published: 2015

Journal Articles

Prognostic Relevance of Integrated Genetic Profiling in Adult T-Cell Leukemia/Lymphoma

Keisuke Kataoka, MD PhD, Yasunobu Nagata, MDPhD, Akira Kitanaka, MD PhD, Jun-ichirou Yasunaga, MDPhD, Masako Iwanaga, MD, PhD, Yuichi Shiraishi, MD PhD, Kenichi Chiba, BA, Aiko Sato-Otsubo, PhD, Masashi Sanada, MD PhD, Hiroko Tanaka, BA, Hiromichi Suzuki, MD PhD, Yusuke Sato, MD PhD, Yusuke Shiozawa, MD, Tetsuichi Yoshizato, MD, Kenichi Yoshida, MD PhD, Hideki Makishima, MD PhD, Kisato Nosaka, MD PhD, Masakatsu Hishizawa, Hidehiro Itonaga, MD PhD, Yoshitaka Imaizumi, MD PhD, Wataru Munakata, MD, Kotaro Shide, MD PhD, Yoko Kubuki, Tomonori Hidaka, Takuro Kameda, Tsuyoshi Nakamaki, MD, Ken Ishiyama, MD PhD, Shuichi Miyawaki, MD, Kensei Tobinai, MD PhD, Yasushi Miyazaki, MD PhD, Akifumi Takaori-Kondo, MD PhD, Tatsuhiro Shibata, Satoru Miyano, MD PhD, Masao Matsuoka, MD PhD, Kazuya Shimoda, MD PhD, Toshiki Watanabe, MD, PhD, Seishi Ogawa, MD PhD

Blood (2015) 126 (23): 2643.

https://doi.org/10.1182/blood.V126.23.2643.2643

Published: 2015

Journal Articles

Next-Generation Sequencing Reveal Proviral Genome and Transcriptome in Adult T-Cell Leukemia/Lymphoma

Blood (2015) 126 (23): 3882.

https://doi.org/10.1182/blood.V126.23.3882.3882

Published: 2015

Journal Articles

Prolonged Lymphocytepenia after Bendamustine with or without Rituximab Treatment in Patients with Relapsed or Refractory Indolent B-Cell and Mantle Cell Lymphoma

Hideaki Saito, MD, Dai Maruyama, MD PhD, Akiko Miyagi Maeshima, MD PhD, Shin-ichi Makita, MD, Hideaki Kitahara, MD, Ken-ichi Miyamoto, MD, Suguru Fukuhara, MD, Wataru Munakata, MD, Tatsuya Suzuki, MD PhD, Yukio Kobayashi, Hirokazu Taniguchi, MD PhD, Kensei Tobinai

Blood (2014) 124 (21): 3066.

https://doi.org/10.1182/blood.V124.21.3066.3066

Published: 2014

NARROW

Clinical Features and Outcomes of Localized Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma: A Dual-Center Retrospective Observational Study with a Long-Term Follow-up

Randomized Phase III Study of Watchful Waiting Vs. Rituximab As First-Line Treatment in Patients with Advanced Stage Low Tumor Burden Follicular Lymphoma: JCOG1411/Flora Study

Number of Sites of Involvement Predicts Central Nervous System Relapse in Patients with Localized Extranodal Natural Killer/T-Cell Lymphoma

Comparison of Clinical Characteristics and Prognosis between Aggressive NK-Cell Leukemia and Advanced-Stage Extranodal NK/T-Cell Lymphoma

Impact of Progression-Free Survival at 24 Months on Subsequent Survival in Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP Therapy: A Supplementary Analysis of JCOG0601

The Prognostic Impact of Relative Dose Intensity of Vincristine in R-CHOP for Untreated Patients with Diffuse Large B-Cell Lymphoma: A Supplementary Analysis of JCOG0601

Final Analysis of the Randomized Phase II/III Study of Standard R-CHOP Versus CHOP Combined with Dose-Dense Weekly Rituximab for DLBCL: JCOG0601

Interim PET-Guided ABVD or ABVD/Escalated BEACOPP for Newly Diagnosed Advanced-Stage Classic Hodgkin Lymphoma (JCOG1305, INNOVATE-HL study)

Phase 2 Study of Tirabrutinib (ONO/GS-4059), a Second-Generation Bruton's Tyrosine Kinase Inhibitor, Monotherapy in Patients with Treatment-Naïve or Relapsed/Refractory Waldenström Macroglobulinemia

Genomics of Limited-Stage Diffuse Large B-Cell Lymphoma Developing Late Relapse: Analysis of Gene Alterations in Paired Primary and Late Relapsed Tumors By Target Sequencing

Prognostic relevance of integrated genetic profiling in adult T-cell leukemia/lymphoma

Impact of the Double Expression of MYC and BCL2 on Outcomes of Primary Refractory Diffuse Large B-Cell Lymphoma Following R-CHOP Chemoimmunotherapy

Comparison of Genetic Profiling of Primary Central Nervous System (CNS) Lymphoma before and after Extra-CNS Relapse

Variegated RHOA mutations in adult T-cell leukemia/lymphoma

Frequent Activating Somatic Alterations in T-Cell Receptor / NF-κb Signaling in Adult T-Cell Leukemia/Lymphoma

Role of FDG-PET/CT in the Staging of Patients with Follicular Lymphoma

Prognostic Relevance of Integrated Genetic Profiling in Adult T-Cell Leukemia/Lymphoma

Next-Generation Sequencing Reveal Proviral Genome and Transcriptome in Adult T-Cell Leukemia/Lymphoma

Prolonged Lymphocytepenia after Bendamustine with or without Rituximab Treatment in Patients with Relapsed or Refractory Indolent B-Cell and Mantle Cell Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only